Hormone-replacement therapy in patients with breast cancer. A reappraisal.

作者: Philip J. Disaia

DOI: 10.1002/CNCR.2820710414

关键词:

摘要: Background. It has been common practice to prohibit hormone-replacement therapy (HRT) in patients with breast cancer. A reappraisal of this is necessary because hundreds reports have established the benefits HRT coronary artery disease, osteoporosis, serum lipid profile, and quality life. Methods. An argument presented support safety use such absence a prospective randomized study addressing these issues. This relies primarily on historical data. Results. There no direct evidence that adversely affects who previously afflicted cancer

参考文章(60)
Holleb Ai, Treves N, A report of 549 cases of breast cancer in women 35 years of age or younger. Surgery gynecology & obstetrics. ,vol. 107, pp. 271- ,(1958)
S. V. Westberg, Prognosis of Breast Cancer for Pregnant and Nursing Women Acta Obstetricia et Gynecologica Scandinavica. ,vol. 25, pp. 1- 239 ,(1946) , 10.3109/00016344609153914
Hiroyuki Kuramoto, Yuzuru Anzai, Erlio Gurpide, Christian F. Holinka, Stimulatory Effects of 4-Hydroxytamoxifen on Proliferation of Human Endometrial Adenocarcinoma Cells (Ishikawa Line) Cancer Research. ,vol. 49, pp. 2362- 2365 ,(1989)
Philip E. Sartwell, Federic G. Arthes, James A. Tonascia, Exogenous Hormones, Reproductive History, and Breast Cancer Journal of the National Cancer Institute. ,vol. 59, pp. 1589- 1592 ,(1977) , 10.1093/JNCI/59.6.1589
STEVEN R. CUMMINGS, JENNIFER L. KELSEY, MICHAEL C. NEVITT, KENNETH J. O'DOWD, EPIDEMIOLOGY OF OSTEOPOROSIS AND OSTEOPOROTIC FRACTURES Epidemiologic Reviews. ,vol. 7, pp. 178- 208 ,(1985) , 10.1093/OXFORDJOURNALS.EPIREV.A036281
C. D. Haagensen, A. P. Stout, CARCINOMA OF THE BREAST: II. CRITERIA OF OPERABILITY. Annals of Surgery. ,vol. 118, pp. 859- 870 ,(1943) , 10.1097/00000658-194311850-00008
Sewa S. Legha, Stephen K. Carter, Antiestrogens in the treatment of breast cancer Cancer Treatment Reviews. ,vol. 3, pp. 205- 216 ,(1976) , 10.1016/S0305-7372(76)80010-2